Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Veritas In Silico Inc. ( (JP:130A) ) just unveiled an update.
Veritas In Silico Inc. has nominated Ms. Tomoko Sato as a candidate for Independent Outside Director, a decision to be confirmed at the company’s 10th Annual General Shareholders’ Meeting in March 2026. With nearly 50 years of experience in the pharmaceutical industry, Ms. Sato is expected to enhance the company’s corporate governance and provide objective management insights, strengthening its operations and market position.
More about Veritas In Silico Inc.
Veritas In Silico Inc. operates in the pharmaceutical industry, focusing on expanding its operations both domestically and internationally. The company is listed on the TSE Growth and is involved in providing specialized knowledge and guidance in the pharmaceutical sector.
Average Trading Volume: 282,266
Technical Sentiment Signal: Sell
Current Market Cap: Yen4.51B
For a thorough assessment of 130A stock, go to TipRanks’ Stock Analysis page.